6-Methoxy-7-Hydroxyquinazolin-4-One CAS 162012-72-8 Gefitinib Intermediate Purity >98.0% (HPLC)

Short Description:

6-Methoxy-7-Hydroxyquinazolin-4-One 

CAS: 162012-72-8

Purity: >98.0% (HPLC)

Appearance: White to Off-White Solid

Intermediate of Gefitinib (CAS: 184475-35-2) 

Contact: Dr. Alvin Huang

Mobile/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

162012-72-8 - Description:

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer of 6-Methoxy-7-Hydroxyquinazolin-4-One (CAS: 162012-72-8) with high quality, intermediate of Gefitinib (CAS: 184475-35-2). Ruifu Chemical can provide worldwide delivery, competitive price, excellent service, small and bulk quantities available. Purchase Gefitinib Intermediates, Please contact: alvin@ruifuchem.com

Gefitinib Intermediates:

162012-72-8 - Chemical Properties:

Chemical Name 6-Methoxy-7-Hydroxyquinazolin-4-One 
Synonyms 7-Hydroxy-6-Methoxyquinazolin-4(1H)-One; 7-Hydroxy-6-Methoxy-3,4-Dihydroquinazolin-4-One; 7-Hydroxy-6-Methoxy-3H-Quinazolin-4-One; 7-Hydroxy-6-Methoxy-4(3H)-Quinazolinone; Gefitinib Intermediate 3
Stock Status In Stock, Commercial Production  
CAS Number 162012-72-8
Molecular Formula C9H8N2O3
Molecular Weight 192.17 g/mol
Melting Point >255℃(dec.)  
Density 1.47±0.10 g/cm3 
COA & MSDS Available
Place of Origin  Shanghai, China
Product Categories
Pharmaceutical Intermediates
Brand Ruifu Chemical

162012-72-8 - Specifications:

Items Specifications  Results
Appearance White to Off-White Solid White Solid  
Purity / Analysis Method        >98.0% (HPLC Area)  98.63%
1H NMR Spectrum Consistent with Structure Complies
Conclusion The product has been tested and complies with the given specifications

162012-72-8 - Package/Storage/Shipping:

Package: Fluorinated Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.
Storage Condition: Keep the container tightly closed and store in a cool, dry, well-ventilated warehouse away from incompatible substances. Keep away from sunshine; avoid fire and heat sources; avoid moisture.
Shipping: Deliver to worldwide by air, by FedEx / DHL Express. Provide fast and reliable delivery. 

Advantages:

Sufficient Capacity: Sufficient facilities and technicians

Professional Service: One stop purchasing service

OEM Package: Custom package and label available

Fast Delivery: If within stock, three days delivery guaranteed

Stable Supply: Maintain reasonable stock    

Technical Support: Technology solution available

Custom Synthesis Service: Ranged from grams to kilos

High Quality: Established a complete quality assurance system

FAQ:

How to Purchase? Please contact Dr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com 

15 Years Experience? We have more than 15 years of experience in the manufacture and export of a wide range of high quality pharmaceutical intermediates or fine chemicals.

Main Markets? Sell to domestic market, North America, Europe, India, Korea, Japanese, Australia, etc.

Advantages? Superior quality, affordable price, professional services and technical support, fast delivery.

Quality AssuranceStrict quality control system. Professional equipment for analysis include NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, K.F, ROI, LOD, MP, Clarity, Solubility, Microbial limit test, etc.

SamplesMost products provide free samples for quality evaluation, shipping cost should be paid by customers.

Factory AuditFactory audit welcome. Please make an appointment in advance.

MOQ? No MOQ. Small order is acceptable.

Delivery Time? If within stock, three days delivery guaranteed.

TransportationBy Express (FedEx, DHL), by Air, by Sea.

Documents? After sales service: COA, MOA, ROS, MSDS, etc. can be provided.

Custom SynthesisCan provide custom synthesis services to best fit your research needs.

Payment TermsProforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T (Telex Transfer), PayPal, Western Union, etc. 

162012-72-8 - Application:

6-Methoxy-7-Hydroxyquinazolin-4-One (CAS: 162012-72-8), intermediate of Gefitinib (CAS: 184475-35-2). Gefitinib is an antineoplastic target therapy drug with relatively high specificity that was developed by the British pharmaceutical company AstraZeneca; it is the first molecular targeted drug to be used in non-small cell lung cancer treatment. Epidermal growth factors (EGF) are a kind of polypeptide with a relative molecular mass of 6.45x103, and they can bind with epidermal growth factor receptors (EGFR) on target cell membrane surfaces to trigger biological effects. EGFR is a type of tyrosine kinase (TK) type receptor, so when bound with EGF, it will promote TK activation in the receptor. This will cause tyrosine residue in the receptor to autophosphorylate and send continuous dividing signals into the cell, causing cell proliferation and differentiation. EGFR is abundant in human tissue, and it is highly expressed in malign tumors. Gefitinib blocks the signal transduction pathway of cell surface EGFR to prevent tumor growth, metastasis, and growth in blood vessels, and it can induce tumor cell apoptosis. Gefitinib is mainly used to treat non-stem cell lung cancer.

  • Write your message here and send it to us